Statistical hypothesis testing

Beware fake Covid tests: how to tell the good from the ugly

Retrieved on: 
Tuesday, June 30, 2020
Partulidae, Biohit, Statistical hypothesis testing, Eua, Eua, Companies

The trick is making sure the test you take, has a high probability of accuracy and is coming from a reputable company authorized to sell it.

Key Points: 
  • The trick is making sure the test you take, has a high probability of accuracy and is coming from a reputable company authorized to sell it.
  • Unfortunately in this competitive industry some companies claim they have a EUA authorization, when in reality they do not.
  • It is concerning but it shows the importance of using testing with EUA authorization as well as third party validations like Yale.
  • For more information and to order the Biohit test kit contact: biotestingsupplies.com
    View original content to download multimedia: http://www.prnewswire.com/news-releases/beware-fake-covid-tests-how-to-t...

PharmaCyte Biotech’s COVID-19 Test Offers “Pool Testing” Dr. Fauci and White House Coronavirus Task Force Now Considering

Retrieved on: 
Monday, June 29, 2020
Medical tests, Medicine, Medical terminology, Prevention, Screening, Statistical hypothesis testing, Tests, Health

Pool testing involves combining or pooling samples from multiple people and testing them together in a single batch.

Key Points: 
  • Pool testing involves combining or pooling samples from multiple people and testing them together in a single batch.
  • One of the key selling points for PharmaCytes testing kits is that they are ideally suited for the mass testing that Dr. Fauci is convinced will make a difference.
  • With numbers like these, its clear that many more testing companies will need to join the fight to improve the daily testing requirement.
  • PharmaCytes COVID-19 test is capable of testing hundreds of people at one time using sample pooling or population screening.

RedThread Research Announces Release of Its Latest Study, "Leveling the Field: Making Performance Management Work for Women"

Retrieved on: 
Thursday, June 25, 2020
GARR, Statistical hypothesis testing, Performance, Human behavior, Human activities, Humans

(The latter article was made possible as a result of the financial sponsorship provided by Workhuman, the worlds fastest-growing social recognition and continuous performance management platform.)

Key Points: 
  • (The latter article was made possible as a result of the financial sponsorship provided by Workhuman, the worlds fastest-growing social recognition and continuous performance management platform.)
  • As Garr stated, Our research shows, while performance management appears to be fair and equal on the surface, when you dig below that surface you find statistically significant differences between how women and men experience performance practices.
  • Among the five major findings of our research, the #1 conclusion is: Modern performance management, though its better than previous approaches, is still experienced unequally by women.
  • This research builds on our knowledge coming from more than a decade of study of performance management.

Sema4 to Deliver High Capacity COVID-19 Testing in Partnership with the State of Connecticut

Retrieved on: 
Monday, June 1, 2020
Data management, Medical Supplies, Biotechnology, Technology, Health, Medical devices, Research, Infectious diseases, Software, Genetics, Science, Psychometrics, Branches of biology, Antibody, Glycoproteins, Immunology, Software testing, Statistical hypothesis testing, Connecticut, Test, Academic disciplines, Articles

Sema4 , a patient-centered health intelligence company, today announced a formal partnership with the State of Connecticut to be a COVID-19 testing provider for Connecticut residents.

Key Points: 
  • Sema4 , a patient-centered health intelligence company, today announced a formal partnership with the State of Connecticut to be a COVID-19 testing provider for Connecticut residents.
  • Sema4 is expanding its current COVID-19 viral testing capacity to 10,000 tests per day in early June.
  • A more complete end-to-end digital solution and increased viral testing capacity, coupled with the introduction of antibody testing, builds upon the steps that Sema4 has already taken to help combat COVID-19 in Connecticut.
  • Sema4 is playing a critical role in supporting the state with testing capacity, said Lieutenant Colonel Christopher Chabot, leader of the Connecticut State COVID testing program.

Emma Mattress Outshines Swedish Competitors in Latest Testfakta Test

Retrieved on: 
Wednesday, May 13, 2020
Psychometrics, Bedding, Mattress, Test, Statistical hypothesis testing, Articles, Academic disciplines, Education

With this test win Emma The Sleep Company received its 10th award throughout Europe.

Key Points: 
  • With this test win Emma The Sleep Company received its 10th award throughout Europe.
  • Testfakta evaluated based on 3 tests: Ergonomics/ Breathability Test;Endurance, Strength and Build Quality Tests; as well as The Cover Material and Analysisof Chemicals Test.
  • The Emma Original performed very well in all individual test categories and outperformed competitors with the overall test result of 8.1.In detail, Emma original was the only mattress that fulfilled the requirements for Testfakta Verified in all three weight classes proving that it is a great mattress that suits smaller, medium, and larger body types.
  • Additionally, Emma outperformed all competitors, when testing the second-best mattress only receiving 7.5 as a total grade and did not meet all the necessary requirements in the different test parameters.

Sauce Labs Launches New Machine Learning-Based Analytics Solution to Improve Test Quality

Retrieved on: 
Tuesday, May 12, 2020
Sauce Labs, Benchmark, salesforce.com, Statistical hypothesis testing, Computer companies, Computing, California

The newly released Sauce Labs Continuous Testing Benchmark Report for 2020 reveals that a significant portion of test failures can be traced to a small number of underlying issues impacting a test suite.

Key Points: 
  • The newly released Sauce Labs Continuous Testing Benchmark Report for 2020 reveals that a significant portion of test failures can be traced to a small number of underlying issues impacting a test suite.
  • Were excited to deliver this new resource to aid in the testing communitys collective efforts to improve test quality, increase developer productivity, and build digital confidence.
  • The findings of the 2020 Continuous Testing Benchmark Report underscore just how prevalent poor test quality is among most enterprise organizations.
  • Sauce Labs is a privately held company funded by Toba Capital, Salesforce Ventures, Centerview Capital Technology, IVP, Adams Street Partners, and Riverwood Capital.

Non-Animal Alternatives Testing Market Report 2020-2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 5, 2020
Research, Chemicals, Plastics, Manufacturing, Food, Beverage, Pharmaceutical, Health, Cosmetics, Retail, Science, Other Science, Alternatives to animal testing, Science experiments, Animal testing, Applied ethics, Bioethics, Animal welfare, Market, Statistical hypothesis testing, Testing cosmetics on animals

The "Non-Animal Alternatives Testing Market Global Report 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Non-Animal Alternatives Testing Market Global Report 2020-2030" report has been added to ResearchAndMarkets.com's offering.
  • The companies in the non-animal testing market are increasingly investing in technologies such as organs on the chip technology as an alternative to animal testing.
  • It places the market within the context of the wider non-animal alternatives testing market, and compares it with other markets.
  • It compares the non-animal alternatives testing market with other segments of the non-animal alternatives testing market by size and growth, historic and forecast.

The Nation Needs More Evidence Before Relying on Home Test Collection Kits for COVID-19

Retrieved on: 
Thursday, April 30, 2020
Psychometrics, Articles, Health, Food and Drug Administration, United States Public Health Service, Academic disciplines, Statistical hypothesis testing, Accuracy and precision

However, the FDA's authorization of LabCorp's home test collection kit for COVID-19 on April 20, 2020 raises questions for scientific accuracy and public health.

Key Points: 
  • However, the FDA's authorization of LabCorp's home test collection kit for COVID-19 on April 20, 2020 raises questions for scientific accuracy and public health.
  • We are confident in LabCorp's ability to perform the testing of the samples once they reach their laboratories.
  • But we are concerned that consumers will not carefully follow directions, which could lead to incorrect sample collection.
  • False negative test results could give false reassurance to concerned members of the public, and may soften their adherence to social distancing guidelines."

Vietnam Announces New COVID-19 Test Kit Eliminating Gross Error Made by Incorrect Collection of Samples

Retrieved on: 
Tuesday, April 28, 2020
Psychometrics, Academic disciplines, Design of experiments, Statistical hypothesis testing, Articles, Medical tests, Tests

Studies based on 866 tests performed in China and published on MedRXiV show that suspected false-negative test results can be as high as 30%.

Key Points: 
  • Studies based on 866 tests performed in China and published on MedRXiV show that suspected false-negative test results can be as high as 30%.
  • Clinical samples which have been incorrectly collected will give insufficient DNA result and will be excluded.
  • The test kit will be available for use at the end of April 2020.
  • About the producer of the kit:
    Production and launch of the test kit will take place at the end of April 2020.

Vietnam Announces New COVID-19 Test Kit Eliminating Gross Error Caused by Incorrect Collection of Samples

Retrieved on: 
Tuesday, April 28, 2020
Design of experiments, Medical tests, Error, Tests, Research methods, Spam filtering, Statistical hypothesis testing, Type I and type II errors, Knowledge, Diagnosis of HIV/AIDS, Screening

Studies based on 866 tests performed in China and published on MedRXiV show that suspected false-negative test results can be as high as 30%.

Key Points: 
  • Studies based on 866 tests performed in China and published on MedRXiV show that suspected false-negative test results can be as high as 30%.
  • McLaren, a Miami-based American health management firm, claims that approximately 20% of patients who have been tested in clinics have received false-negative results.
  • Itcan even detect errors in the collection of samples as well as safeguarding the entire diagnostic process.
  • Production and launch of the test kit will take place at the end of April 2020.